Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ

Watchlist Manager
Eckert & Ziegler Strahlen und Medizintechnik AG Logo
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Watchlist
Price: 39.88 EUR 7.84% Market Closed
Market Cap: 831.3m EUR
Have any thoughts about
Eckert & Ziegler Strahlen und Medizintechnik AG?
Write Note

Eckert & Ziegler Strahlen und Medizintechnik AG
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Eckert & Ziegler Strahlen und Medizintechnik AG
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Free Cash Flow
€33.9m
CAGR 3-Years
9%
CAGR 5-Years
2%
CAGR 10-Years
43%
Carl Zeiss Meditec AG
XETRA:AFX
Free Cash Flow
-€15.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stratec SE
XETRA:SBS
Free Cash Flow
€18.4m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Siemens Healthineers AG
XETRA:SHL
Free Cash Flow
€1.5B
CAGR 3-Years
-17%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
Free Cash Flow
€144.4m
CAGR 3-Years
-35%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Sartorius AG
XETRA:SRT
Free Cash Flow
€479m
CAGR 3-Years
5%
CAGR 5-Years
40%
CAGR 10-Years
33%
No Stocks Found

Eckert & Ziegler Strahlen und Medizintechnik AG
Glance View

Market Cap
831.3m EUR
Industry
Health Care

Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. The company is headquartered in Berlin, Berlin and currently employs 866 full-time employees. The company went IPO on 2008-02-25. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

EUZ Intrinsic Value
56.66 EUR
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Eckert & Ziegler Strahlen und Medizintechnik AG's Free Cash Flow?
Free Cash Flow
33.9m EUR

Based on the financial report for Sep 30, 2024, Eckert & Ziegler Strahlen und Medizintechnik AG's Free Cash Flow amounts to 33.9m EUR.

What is Eckert & Ziegler Strahlen und Medizintechnik AG's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
43%

Over the last year, the Free Cash Flow growth was 207%. The average annual Free Cash Flow growth rates for Eckert & Ziegler Strahlen und Medizintechnik AG have been 9% over the past three years , 2% over the past five years , and 43% over the past ten years .

Back to Top